Clinical Trial Detail

NCT ID	NCT01737502
Title	Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Mayo Clinic
Indications	lung small cell carcinoma lung adenocarcinoma lung squamous cell carcinoma
Therapies	Auranofin + Sirolimus
Age Groups:	adult senior